P888: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY

• F. B. Askeland,
• E. Haukås,
• T. S. Slørdahl,
• D. Schjøll,
• A. Lysen,
• E. Hermansen,
• F. Schjesvold

Affiliations

F. B. Askeland

1 Oslo Myeloma Center, Department of Hematology

E. Haukås

3 Department of Cancer and Blood Diseases, Stavanger University Hospital, Stavanger

T. S. Slørdahl

4 Department of Hematology, St. Olavs Hospital, Trondheim, Norway

D. Schjøll

5 Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo

A. Lysen

1 Oslo Myeloma Center, Department of Hematology

E. Hermansen

6 Department of Hematology, Zealand Iniversity Hospital, Roskilde, Denmark

F. Schjesvold

1 Oslo Myeloma Center, Department of Hematology